Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

NCT05960240 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: AB-101
DRUG: Placebo
DRUG: Nucleos(t)ide Analogue

Sponsor

Arbutus Biopharma Corporation